Stereotactic Body Radiation Therapy as an Alternative Treatment for Patients with Hepatocellular Carcinoma Compared to Sorafenib: A Propensity Score Analysis
Conclusions: In this retrospective comparative study, SBRT showed superior efficacy in HCC patients compared to patients treated with sorafenib.Liver Cancer (Source: Liver Cancer)
Source: Liver Cancer - July 12, 2018 Category: Cancer & Oncology Source Type: research
9th Asia-Pacific Primary Liver Cancer Expert Meeting, Seoul, South Korea, July 6-8, 2018
Liver Cancer 2018;7:1 –224 (Source: Liver Cancer)
Source: Liver Cancer - July 5, 2018 Category: Cancer & Oncology Source Type: research
9th Asia-Pacific Primary Liver Cancer Expert Meeting, Seoul, South Korea, July 6-8, 2018
Liver Cancer ;7:I –IV (Source: Liver Cancer)
Source: Liver Cancer - July 5, 2018 Category: Cancer & Oncology Source Type: research
Multibipolar Radiofrequency Ablation for the Treatment of Mass-Forming and Infiltrative Hepatocellular Carcinomas > 5 cm: Long-Term Results
Conclusions: mbp-RFA offers good OS in inoperable patients with cirrhosis and large HCC, with acceptable safety profile. For infiltrative forms, although mbp-RFA leads to complete responses in more than 80% cases, few only remain tumor progression-free in long-term.Liver Cancer (Source: Liver Cancer)
Source: Liver Cancer - June 28, 2018 Category: Cancer & Oncology Source Type: research
Patients with Barcelona Clinic Liver Cancer Stages B and C Hepatocellular Carcinoma: Time for a Subclassification
Background: The Barcelona Clinic Liver Cancer (BCLC) intermediate and advanced stages (BCLC B and C) of hepatocellular carcinoma (HCC) both include heterogeneous populations. Patients classified as BCLC stage B present with different tumour burdens, and the recommended treatment is transarterial chemoembolization (TACE). A similar heterogeneity of tumour burden and liver function can be found among patients classified as BCLC stage C, which includes diverse clinical features (performance status [PS] 1 –2), macrovascular invasion (MVI) including portal vein tumour (PVT) thrombosis, and/or extra-hepatic spread. Nonetheless...
Source: Liver Cancer - June 27, 2018 Category: Cancer & Oncology Source Type: research